Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, May 5, 2014

Hemostemix Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium

Hemostemix is a clinical-stage Canadian-Israeli company developing and commercializing innovative blood-derived cell therapies for unmet medical conditions Hemostemix's expertise with blood-derived therapies and manufacturing cells for patients complements the development work taking place at CCRM.

http://ift.tt/RkrDUb
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts